Unknown

Dataset Information

Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.


ABSTRACT:

Aims

In previous studies, the histamine-3 receptor antagonist CEP-26401 had a subtle effect on spatial working memory, with the best effect seen at the lowest dose tested (20 μg), and a dose-dependent disruption of sleep. In the current study, 3 low-dose levels of CEP-26401 were compared with modafinil and donepezil.

Methods

In this double-blind, placebo- and positive-controlled, randomized, partial 6-way cross-over study, 40 healthy subjects received single doses of placebo, CEP-26401 (5, 25 or 125 μg) or modafinil 200 mg or donepezil 10 mg. Pharmacokinetic and pharmacodynamic measurements were performed predose and at designated time points postdose.

Results

The main endpoint between-errors of the spatial working memory-10-boxes task only improved for the 125 μg dos

SUBMITTER: Baakman AC 

PROVIDER: S-EPMC6475682 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature